An insurance denial is not a single diagnosis. It is a message that something in the requested coverage pathway did not meet the payer's current rules — or that the payer did not receive what it needed.
Turn the denial into a checklist
- Get the actual denial reason. Do not work from “insurance denied it” alone. Read the letter, portal message or authorization response.
- Confirm the exact medicine and formulation. Similar brands, biosimilars, IV versus subcutaneous formulations, and new billing codes can have different rules.
- Find the current payer policy. Check diagnosis criteria, required prior therapies, preferred products, dose limits, benefit channel and site-of-care rules.
- Check whether the request was administratively correct. Wrong HCPCS units, wrong benefit, missing records or a mismatched treatment site can derail an otherwise covered therapy.
- Use the plan's review or appeal process. The provider may be able to resubmit, request reconsideration, conduct a peer-to-peer review or file an appeal depending on the plan and denial type.
- Attack cost separately. Even after coverage is approved, manufacturer support or independent charitable assistance may be needed for the patient's remaining out-of-pocket cost.
Why the official denial reason matters
For many health plans, an appeal is much stronger when it responds to the actual coverage criterion rather than simply restating that the treatment is needed. The treatment team should use the plan's current process and deadlines.
Patients have appeal rights
Appeal rules differ by coverage type. Marketplace and many private plans have internal and external review rights; Medicare and Medicaid have their own processes. Use the denial notice and the plan's official instructions rather than assuming one appeal process fits everyone.